AZTA · Azenta, Inc.
Market Cap
$1.39B
Shares
43.81M
AZTA metrics
86 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$31.73
Market cap
$1.39B
Price action
19 metricsPrice change (1W)
-4.9%
Price change (30D)
+5.7%
Price change (3M)
+34.7%
Price change (6M)
+28.6%
Price change (YTD)
-5.1%
Price change (1Y)
+3.4%
Trailing year
Price change (5Y)
-63.0%
52-week high
$41.01
52-week low
$16.02
Change from 52-week high
-23.0%
Change from 52-week low
+97.1%
Annualized volatility
61.8%
Beta
1.5
RSI (14D)
48.2
Price vs SMA 50
+7.9%
Price vs SMA 200
+11.6%
Avg volume (3M)
745,365
Relative volume
2.0
Average dollar volume
$20.68M
Company
3 metricsSector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
43.81M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.3×
reciprocal yield 42.9%
P / book
0.9
reciprocal yield 105.6%
FCF yield
0.7%
TTM · current market cap
Buyback yield
0.0%
P / FCF
144.8
reciprocal yield 0.7%
P / operating cash flow
37.7
reciprocal yield 2.7%
Earnings yield
-8.6%
Historical valuation
8 metricsP / E historical average (3Y)
36.0×
reciprocal yield 2.8%
P / E historical average (5Y)
36.0×
reciprocal yield 2.8%
EV / revenue historical average (3Y)
7.6×
reciprocal yield 13.2%
EV / revenue historical average (5Y)
7.6×
reciprocal yield 13.2%
EV / EBIT historical average (3Y)
54.0×
reciprocal yield 1.9%
EV / EBIT historical average (5Y)
54.0×
reciprocal yield 1.9%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
2021-12-02
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-05
Profitability
9 metricsGross margin
44.0%
Operating margin
-28.6%
Trailing 12 months
Net margin
-20.0%
Gross profit (TTM)
$270.37M
Operating profit (TTM)
−$175.30M
Net income (TTM)
−$122.90M
Trailing 12 months
Diluted EPS (TTM)
$-2.67
FCF margin
1.6%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+12.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$613.81M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-1.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.2%
Revenue CAGR (5Y)
+8.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-8.1%
Return on assets
-6.6%
Debt / equity
—
Current ratio
2.5
EBITDA (TTM)
−$119.64M
Free cash flow (TTM)
$9.88M
Quick ratio
2.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$189.65M
Total assets
$1.88B
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$37.98M
Capital expenditures (TTM)
$28.09M
R&D (TTM)
$35.73M
SG&A (TTM)
$257.38M
Stock compensation (TTM)
$19.40M
R&D / revenue
5.8%
Stock compensation / revenue
3.2%
Ownership (13F)
3 metrics13F filers
249
13F filer change QoQ
-13
Institutional ownership
115.6%
Short interest
3 metricsShort interest
12.0%
Latest settlement · 7.1 days to cover
Days to cover
7.1d
Short-squeeze score
75 / 100
Insider activity
2 metricsNet insider buying (90D)
$8,096
Insider-sentiment score
73 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
933974
CUSIP
114340102
13F (30d)
221 filings
206 filers
Visit website
Investor relations